Blue Horizon International is a healthcare-management and research organization focused on advancing scientific research and education in regenerative medicine. We collaborate with academic and clinical partners, including affiliations with university research institutions, and our affiliates operate in accordance with the applicable regulatory requirements of the jurisdictions in which they are licensed. Our cellular and exosome products are investigational and are not approved by the U.S. FDA.

The statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Our cellular and exosome products are investigational, are not FDA-approved, and are not intended to diagnose, treat, cure, or prevent any disease. The information provided here is for educational purposes only and is not medical advice.